Article
Selective inhibition of Abeta42 production by NSAID R-enantiomers.
Journal of neurochemistry - 1 Nov 2002
Morihara T, Chu T, Ubeda O, Beech W, Cole G M
Abstract excerpt
Non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with reduced risk for Alzheimer's disease (AD) and selected NSAIDs racemates suppress beta-amyloid (Abeta) accumulation in vivo and Abeta42 production in vitro. Clinical use of NSAIDs for preventing or treating AD has been hampered by dose-limiting toxicity believed to be due to cyclooxygenase (COX)-inhibition that is reportedly not essential for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
